BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16235089)

  • 21. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.
    Sartoris S; Tosi G; De Lerma Barbaro A; Cestari T; Accolla RS
    Eur J Immunol; 1996 Oct; 26(10):2456-60. PubMed ID: 8898960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of MHC class II expression in human T-cell malignancies.
    Holling TM; Schooten E; Langerak AW; van den Elsen PJ
    Blood; 2004 Feb; 103(4):1438-44. PubMed ID: 14563641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic expression of MHC class II is driven by mitogen-activated protein kinases.
    Martins I; Deshayes F; Baton F; Forget A; Ciechomska I; Sylla K; Aoudjit F; Charron D; Al-Daccak R; Alcaide-Loridan C
    Eur J Immunol; 2007 Mar; 37(3):788-97. PubMed ID: 17304627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
    Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
    Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
    Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
    Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.
    LeibundGut-Landmann S; Waldburger JM; Krawczyk M; Otten LA; Suter T; Fontana A; Acha-Orbea H; Reith W
    Eur J Immunol; 2004 Jun; 34(6):1513-25. PubMed ID: 15162420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
    Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
    J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
    Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative control of MHC class II expression by the transactivator CIITA.
    Otten LA; Steimle V; Bontron S; Mach B
    Eur J Immunol; 1998 Feb; 28(2):473-8. PubMed ID: 9521055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation.
    Cai Q; Banerjee S; Cervini A; Lu J; Hislop AD; Dzeng R; Robertson ES
    PLoS Pathog; 2013 Oct; 9(10):e1003751. PubMed ID: 24204280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells.
    Chou SD; Khan AN; Magner WJ; Tomasi TB
    Int Immunol; 2005 Nov; 17(11):1483-94. PubMed ID: 16210330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cells.
    Murphy SP; Holtz R; Lewandowski N; Tomasi TB; Fuji H
    J Immunol; 2002 Sep; 169(6):3085-93. PubMed ID: 12218125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases.
    Yau AC; Piehl F; Olsson T; Holmdahl R
    Immunology; 2017 Apr; 150(4):408-417. PubMed ID: 27861821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
    Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in myelomonocytic cells.
    De Lerma Barbaro A; Procopio FA; Mortara L; Tosi G; Accolla RS
    Eur J Immunol; 2005 Feb; 35(2):603-11. PubMed ID: 15627980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of human sepsis on CCCTC-binding factor associated monocyte transcriptional response of Major Histocompatibility Complex II components.
    Siegler BH; Uhle F; Lichtenstern C; Arens C; Bartkuhn M; Weigand MA; Weiterer S
    PLoS One; 2018; 13(9):e0204168. PubMed ID: 30212590
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Sengupta S; Naz S; Das I; Ahad A; Padhi A; Naik SK; Ganguli G; Pattanaik KP; Raghav SK; Nandicoori VK; Sonawane A
    J Biol Chem; 2017 Apr; 292(17):6855-6868. PubMed ID: 28209712
    [No Abstract]   [Full Text] [Related]  

  • 39. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
    Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
    J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class II transactivator-induced MHC class II expression in pancreatic cancer cells leads to tumor rejection and a specific antitumor memory response.
    Ekkirala CR; Cappello P; Accolla RS; Giovarelli M; Romero I; Garrido C; Garcia-Lora AM; Novelli F
    Pancreas; 2014 Oct; 43(7):1066-72. PubMed ID: 24987872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.